amifostine anhydrous has been researched along with Disease Models, Animal in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.03) | 18.7374 |
1990's | 7 (21.21) | 18.2507 |
2000's | 10 (30.30) | 29.6817 |
2010's | 12 (36.36) | 24.3611 |
2020's | 3 (9.09) | 2.80 |
Authors | Studies |
---|---|
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Cheng, Y; Du, J; Huang, S; Pan, L; Wu, X; Yang, W; Zhang, M; Zhang, Y; Zhu, H | 1 |
Huang, G; Li, K; Tian, H; Zhang, J; Zhang, Q; Zhu, Z | 1 |
Huang, KY; Ji, KT; Li, L; Lin, JF; Tao, LY; Wang, J; Wang, JN; Wu, SZ; Xu, ZQ; Xue, YJ | 1 |
Alencar, NMN; Barbosa, CRN; Barbosa, SCM; Brito, GAC; Callado, RB; Carvalho, LL; Lima-Júnior, RCP; Lopes, CDH; Lucetti, LT; Pereira, VBM; Santana, APM; Silva, CAA; Wong, DVT | 1 |
Benel, L; Bloy, C; Bricout, D; Chargari, C; Clémenson, C; Deutsch, E; Haddad, R; Liu, W; Mondini, M; Soyez-Herkert, L; Wang-Zhang, X | 1 |
Harsini, S; Javan-Farazmand, N; Kajbafzadeh, AM; Sabetkish, N; Sabetkish, S; Tavangar, SM | 1 |
Dagdeviren, A; Gulumser, C; Mulayim, B; Onalan, G; Zeyneloglu, H | 1 |
Buchman, SR; Deshpande, SS; Donneys, A; Poushanchi, B; Sarhaddi, D; Tchanque-Fossuo, CN; Weiss, DM | 1 |
Akbulut, S; Dogan, Z; Elbe, H; Erdemli, E; Eris, C; Otan, E; Toprak, G; Turkoz, Y | 1 |
Cengiz, A; Cengiz, K; Demir, N; Goksu, E; Gurer, I; Kazan, S; Ozsoy, O; Tan, R | 1 |
Chan, LP; Chang, LC; Chen, CH; Kuo, ML; Liao, WC; Lin, J; Wang, JL | 1 |
Buchman, SR; Deshpande, SS; Donneys, A; Felice, PA; Nelson, NS; Polyatskaya, Y; Rodriguez, JJ; Zheutlin, AR | 1 |
Bougioukas, I; Danner, BC; Didilis, V; Emigholz, J; Mühlfeld, C; Schoendube, FA; Stojanovic, T; Waldmann-Beushausen, R | 1 |
Mehrara, BJ; Mei, L; Schönmeyr, BH; Soares, MA; Wong, AK | 1 |
Damron, TA; Farnum, CE; Margulies, BS; O'Hara, K; Spadaro, JA; Strauss, JA | 1 |
Allen, M; Damron, T; Margulies, B; Morgan, H; Spadaro, J; Strauss, J | 1 |
DeRemer, SJ; Dou, C; Ensminger, WD; Levi, M; Smith, DE | 1 |
Blakley, BW; Burgio, DL; Church, MW; Gupta, AK | 1 |
Bali, M; Barun, S; Dileköz, E; Ercan, ZS; Erten, Y; Ertoy, D; Müftüoglu, S; Sarioglu, Y; Sucak, G; Tekeli, N | 1 |
Damron, TA; Farnum, CE; Horton, JA; Luther, J; Margulies, BS; Spadaro, JA; Strauss, JA | 1 |
Baverel, G; Dubourg, L; Michoudet, C; Yaseen, Z | 1 |
Asmis, R; Brown, SA; Chu, Y; Glass, J; Nelson, B; Thompson, JS | 1 |
Clark, JI; Livesey, JC; Steele, JE | 1 |
Capizzi, RL; Johnson, CS; Lopez, MH; Paine, GD; Taylor, CW | 1 |
Lenoble, M | 1 |
Becker, M; Berthold, F; Fichtner, I; Lemm, M | 1 |
Calabresi, P; Kuhn, C; Nici, L; Santos-Moore, A | 1 |
Damron, TA; Spadaro, JA; Tamurian, RM | 1 |
Bohuslavizki, KH; Brenner, W; Clausen, M; Feyerabend, B; Henze, E; Jenicke, L; Klutmann, S | 1 |
Grau, C; Lindegaard, JC | 1 |
Attie, MF; Fallon, MD; Farber, J; Goldfarb, S; Shaker, JL | 1 |
2 review(s) available for amifostine anhydrous and Disease Models, Animal
Article | Year |
---|---|
[Amifostine: current and future applications in cytoprotection].
Topics: Amifostine; Animals; Antineoplastic Agents; Bone Marrow; Disease Models, Animal; Drug Tolerance; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Kidney; Neoplasms; Neoplasms, Experimental; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy | 1996 |
Has the outlook improved for amifostine as a clinical radioprotector?
Topics: Amifostine; Animals; Clinical Trials as Topic; Disease Models, Animal; Dogs; Dose-Response Relationship, Radiation; Female; Humans; Male; Mice; Radiation Dosage; Radiation Injuries; Radiation-Protective Agents; Sensitivity and Specificity; Xerostomia | 2000 |
1 trial(s) available for amifostine anhydrous and Disease Models, Animal
Article | Year |
---|---|
[Amifostine: current and future applications in cytoprotection].
Topics: Amifostine; Animals; Antineoplastic Agents; Bone Marrow; Disease Models, Animal; Drug Tolerance; Hematopoietic Stem Cells; Humans; In Vitro Techniques; Kidney; Neoplasms; Neoplasms, Experimental; Prospective Studies; Radiation Injuries; Radiation-Protective Agents; Radiotherapy | 1996 |
31 other study(ies) available for amifostine anhydrous and Disease Models, Animal
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Amifostine attenuates bleomycin-induced pulmonary fibrosis in mice through inhibition of the PI3K/Akt/mTOR signaling pathway.
Topics: Amifostine; Animals; Bleomycin; Disease Models, Animal; Mammals; Mice; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Signal Transduction; TOR Serine-Threonine Kinases | 2023 |
Polycysteine as a new type of radio-protector ameliorated tissue injury through inhibiting ferroptosis in mice.
Topics: Amifostine; Animals; Cell Line; Disease Models, Animal; DNA; Ferroptosis; Glutathione; Hematopoietic Stem Cells; Intestinal Mucosa; Jejunum; Lipid Peroxidation; Lung; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Oxidative Stress; Peptides; Radiation Dosage; Radiation Injuries; Radiation-Protective Agents; Rats; Whole-Body Irradiation | 2021 |
Amifostine Pretreatment Attenuates Myocardial Ischemia/Reperfusion Injury by Inhibiting Apoptosis and Oxidative Stress.
Topics: Amifostine; Animals; Apoptosis; Cell Survival; Cells, Cultured; Disease Models, Animal; Mice; Mitochondria; Myocardial Reperfusion Injury; Oxidative Stress; Pre-Exposure Prophylaxis; Radiation-Protective Agents | 2017 |
Amifostine reduces inflammation and protects against 5-fluorouracil-induced oral mucositis and hyposalivation.
Topics: Amifostine; Animals; Cricetinae; Disease Models, Animal; Fluorouracil; Inflammation; Male; Protective Agents; Stomatitis; Xerostomia | 2019 |
Preventing Radiation-Induced Injury by Topical Application of an Amifostine Metabolite-Loaded Thermogel.
Topics: Amifostine; Animals; Blood Pressure; Breast Neoplasms; Disease Models, Animal; DNA Damage; Dogs; Drug Carriers; Female; Gels; Head and Neck Neoplasms; Hypotension, Orthostatic; Mice; Mice, Inbred C57BL; Radiation Injuries, Experimental; Radiation-Protective Agents; Radiodermatitis; Random Allocation; Skin Neoplasms; Stomatitis | 2019 |
The ameliorative effect of various antioxidants on Adriamycin-induced fetal renal abnormalities.
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Antioxidants; Deferoxamine; Disease Models, Animal; Doxorubicin; Female; Fetal Diseases; Hydronephrosis; Kidney; Pregnancy; Prenatal Exposure Delayed Effects; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Siderophores | 2013 |
Effects of amifostine on endometriosis, comparison with N-acetyl cysteine, and leuprolide as a new treatment alternative: a randomized controlled trial.
Topics: Abdominal Wall; Acetylcysteine; Amifostine; Animals; Disease Models, Animal; Endometriosis; Endometrium; Female; Leuprolide; Peritoneal Diseases; Peritoneum; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2014 |
Amifostine protects vascularity and improves union in a model of irradiated mandibular fracture healing.
Topics: Amifostine; Animals; Disease Models, Animal; Fracture Healing; Humans; Mandible; Mandibular Fractures; Neovascularization, Physiologic; Osteonecrosis; Osteotomy; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Rats | 2013 |
Cytoprotective effects of amifostine, ascorbic acid and N-acetylcysteine against methotrexate-induced hepatotoxicity in rats.
Topics: Acetylcysteine; Amifostine; Animals; Antioxidants; Ascorbic Acid; Biomarkers; Chemical and Drug Induced Liver Injury; Cytoprotection; Disease Models, Animal; Liver; Male; Methotrexate; Oxidative Stress; Rats, Sprague-Dawley; Time Factors | 2014 |
The effect of amifostine on pathophysiological changes in vasogenic brain edema induced by an experimental cold injury model.
Topics: Amifostine; Animals; Brain Edema; Brain Injuries; Cold Temperature; Dexamethasone; Disease Models, Animal; Malondialdehyde; Neuroprotective Agents; Peroxidase; Rats | 2015 |
CCM-AMI, a Polyethylene Glycol Micelle with Amifostine, as an Acute Radiation Syndrome Protectant in C57BL/6 Mice.
Topics: Acute Radiation Syndrome; Amifostine; Animals; Disease Models, Animal; Dose-Response Relationship, Radiation; Male; Mercaptoethylamines; Mice; Mice, Inbred C57BL; Micelles; Polyethylene Glycols; Radiation-Protective Agents; Whole-Body Irradiation | 2015 |
Prophylactic amifostine prevents a pathologic vascular response in a murine model of expander-based breast reconstruction.
Topics: Amifostine; Angiography; Animals; Breast Neoplasms; Disease Models, Animal; Dose-Response Relationship, Drug; Imaging, Three-Dimensional; Male; Mammaplasty; Mammary Arteries; Neoplasms, Experimental; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Tissue Expansion Devices | 2016 |
The effect of amifostine on lung ischaemia-reperfusion injury in rats.
Topics: Amifostine; Animals; Disease Models, Animal; Inflammation Mediators; Ischemia; Lung; Male; NF-kappa B; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury | 2016 |
Radioprotection of osteoblasts by a fractionated dose regimen and amifostine.
Topics: Amifostine; Animals; Animals, Newborn; Cell Differentiation; Cell Proliferation; Cell Survival; Disease Models, Animal; Dose Fractionation, Radiation; Osteoblasts; Radiation-Protective Agents; Rats; Vascular Endothelial Growth Factor A | 2009 |
Sequential histomorphometric analysis of the growth plate following irradiation with and without radioprotection.
Topics: Age Factors; Amifostine; Animals; Anthropometry; Chondrocytes; Disease Models, Animal; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Femur; Growth Plate; Hindlimb; Immunohistochemistry; Male; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia; Time Factors | 2003 |
Transiently increased bone density after irradiation and the radioprotectant drug amifostine in a rat model.
Topics: Amifostine; Animals; Bone Density; Disease Models, Animal; Hindlimb; Male; Osteoclasts; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley | 2003 |
Disposition of WR-1065 in the liver of tumor-bearing rats following regional vs systemic administration of amifostine.
Topics: Amifostine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Disease Models, Animal; Drug Delivery Systems; Drug Screening Assays, Antitumor; Femoral Vein; Infusions, Intravenous; Liver Neoplasms, Experimental; Male; Mercaptoethylamines; Neoplasm Transplantation; Portal Vein; Prodrugs; Rats; Rats, Sprague-Dawley | 2004 |
WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
Topics: Amifostine; Animals; Auditory Threshold; Cisplatin; Cochlea; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Evoked Potentials, Auditory; Hearing Loss; Male; Mesocricetus; Radiation-Protective Agents; Radiation-Sensitizing Agents; Reaction Time | 2004 |
Effects of amifostine on glycerol-pretreated rabbit kidneys.
Topics: Acetylcholine; Acute Kidney Injury; Amifostine; Animals; Antioxidants; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycerol; In Vitro Techniques; Kidney; Male; Perfusion; Rabbits; Renal Artery; Vasodilation; Vasodilator Agents | 2005 |
Radioprotectant combinations spare radiation-induced damage to the physis more than fractionation alone.
Topics: Amifostine; Animals; Anti-Ulcer Agents; Bone Development; Disease Models, Animal; Dose Fractionation, Radiation; Knee Joint; Male; Misoprostol; Pentoxifylline; Radiation Injuries; Radiation-Protective Agents; Random Allocation; Rats; Rats, Sprague-Dawley; Tibia | 2005 |
In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
Topics: Acetaldehyde; Acetyl Coenzyme A; Adenosine Triphosphate; Amifostine; Animals; Disease Models, Animal; Drug Therapy, Combination; Glutathione; Glutathione Disulfide; Injections, Intraperitoneal; Kidney; Kidney Diseases; Kidney Tubules, Proximal; Male; Mesna; Organ Culture Techniques; Radiation-Protective Agents; Rats; Rats, Wistar | 2008 |
Amifostine prior to lethal irradiation prevents allogeneic bone marrow engraftment in mice.
Topics: Amifostine; Animals; Bone Marrow Transplantation; Disease Models, Animal; Graft Rejection; Graft Survival; Graft vs Host Disease; Mice; Mice, Inbred BALB C; Radiation-Protective Agents; Transplantation Conditioning; Transplantation, Homologous; Whole-Body Irradiation | 2008 |
Phase separation inhibitors and lens transparency.
Topics: Amifostine; Animals; Cataract; Disease Models, Animal; Female; Galactose; Lens, Crystalline; Male; Radiation Injuries, Experimental; Radiation-Sensitizing Agents; Rats; Rats, Mutant Strains; Rats, Sprague-Dawley; Sodium Selenite; Streptozocin | 1993 |
Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.
Topics: Amifostine; Animals; Antineoplastic Agents, Phytogenic; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Mice; Mice, SCID; Ovarian Neoplasms; Paclitaxel; Radiation-Protective Agents; Tumor Cells, Cultured | 1996 |
Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas.
Topics: Amifostine; Animals; Antineoplastic Agents; Blood Platelets; Body Weight; Disease Models, Animal; Female; Humans; Leukocytes; Male; Mice; Mice, Nude; Neuroblastoma; Radiation-Protective Agents; Transplantation, Heterologous | 1997 |
Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Topics: Amifostine; Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Collagen; Cricetinae; Disease Models, Animal; Drug Evaluation, Preclinical; Male; Organ Size; Pulmonary Fibrosis | 1998 |
Sparing radiation-induced damage to the physis by radioprotectant drugs: laboratory analysis in a rat model.
Topics: Amifostine; Animals; Bone Development; Disease Models, Animal; Femur; Growth Plate; Hindlimb; Pilot Projects; Radiation Injuries, Experimental; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Tibia; X-Rays | 1999 |
Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model.
Topics: Amifostine; Animals; Disease Models, Animal; Drug Evaluation, Preclinical; Iodine Radioisotopes; Male; Rabbits; Radiation-Protective Agents; Radiobiology; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Salivary Glands; Sodium Pertechnetate Tc 99m | 1999 |
WR-2721 reduces bone loss after hindlimb tenotomy in rats.
Topics: Amifostine; Animals; Bone Resorption; Calcium; Data Interpretation, Statistical; Disease Models, Animal; Femur; Hindlimb; Male; Organ Size; Organothiophosphorus Compounds; Rats; Rats, Inbred Strains; Tendons | 1989 |